353 related articles for article (PubMed ID: 28873971)
1. Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2-5 and on dialysis.
Shroff R; Wan M; Nagler EV; Bakkaloglu S; Cozzolino M; Bacchetta J; Edefonti A; Stefanidis CJ; Vande Walle J; Ariceta G; Klaus G; Haffner D; Schmitt CP;
Nephrol Dial Transplant; 2017 Jul; 32(7):1114-1127. PubMed ID: 28873971
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2-5 and on dialysis.
Shroff R; Wan M; Nagler EV; Bakkaloglu S; Fischer DC; Bishop N; Cozzolino M; Bacchetta J; Edefonti A; Stefanidis CJ; Vande Walle J; Haffner D; Klaus G; Schmitt CP;
Nephrol Dial Transplant; 2017 Jul; 32(7):1098-1113. PubMed ID: 28873969
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
[TBL] [Abstract][Full Text] [Related]
4. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
5. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D;
Nephrol Dial Transplant; 2021 Feb; 36(3):413-425. PubMed ID: 33245331
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines.
Christodoulou M; Aspray TJ; Schoenmakers I
Calcif Tissue Int; 2021 Aug; 109(2):157-178. PubMed ID: 33895867
[TBL] [Abstract][Full Text] [Related]
8. Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement.
Evenepoel P; Jørgensen HS; Bover J; Davenport A; Bacchetta J; Haarhaus M; Hansen D; Gracia-Iguacel C; Ketteler M; McAlister L; White E; Mazzaferro S; Vervloet M; Shroff R
Nephrol Dial Transplant; 2024 Jan; 39(2):341-366. PubMed ID: 37697718
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.
Bacchetta J; Schmitt CP; Ariceta G; Bakkaloglu SA; Groothoff J; Wan M; Vervloet M; Shroff R; Haffner D;
Nephrol Dial Transplant; 2020 Jan; 35(1):47-64. PubMed ID: 31641778
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
11. To what extent can we achieve mineral bone metabolism treatment targets suggested by the KDIGO guidelines among chronic kidney disease stage 3 - 5 non-dialysis patients?
Dincer MT; Ozcan SG; Alagoz S; Karaca C; Gulcicek SH; Trabulus S; Pekpak M; Seyahi N
Clin Nephrol; 2022 Nov; 98(5):239-246. PubMed ID: 35979902
[TBL] [Abstract][Full Text] [Related]
12. [Utilization of alfacalcidol and active vitamin D analogs in chronic kidney disease].
Ureña-Torres PA; Cozzolino M; Bover J
Nephrol Ther; 2018 Jun; 14(4):189-200. PubMed ID: 29545131
[TBL] [Abstract][Full Text] [Related]
13. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB
Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995
[TBL] [Abstract][Full Text] [Related]
14. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
Goldsmith DJ; Massy ZA; Brandenburg V
Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
[TBL] [Abstract][Full Text] [Related]
15. Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group.
Shroff R; Calder F; Bakkaloğlu S; Nagler EV; Stuart S; Stronach L; Schmitt CP; Heckert KH; Bourquelot P; Wagner AM; Paglialonga F; Mitra S; Stefanidis CJ;
Nephrol Dial Transplant; 2019 Oct; 34(10):1746-1765. PubMed ID: 30859187
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.
Morrone LF; Bolasco P; Camerini C; Cianciolo G; Cupisti A; Galassi A; Mazzaferro S; Russo D; Russo L; Cozzolino M
J Nephrol; 2016 Jun; 29(3):305-328. PubMed ID: 27062486
[TBL] [Abstract][Full Text] [Related]
17. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
Bover J; Ureña-Torres P; Lloret MJ; Ruiz C; DaSilva I; Diaz-Encarnacion MM; Mercado C; Mateu S; Fernández E; Ballarin J
Expert Opin Pharmacother; 2016 Jul; 17(10):1363-73. PubMed ID: 27156578
[TBL] [Abstract][Full Text] [Related]
18. Native vitamin D in pre-dialysis chronic kidney disease.
Cardoso MP; Pereira LAL
Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
[TBL] [Abstract][Full Text] [Related]
19. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
Gallieni M; De Luca N; Santoro D; Meneghel G; Formica M; Grandaliano G; Pizzarelli F; Cossu M; Segoloni G; Quintaliani G; Di Giulio S; Pisani A; Malaguti M; Marseglia C; Oldrizzi L; Pacilio M; Conte G; Dal Canton A; Minutolo R
J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
[TBL] [Abstract][Full Text] [Related]
20. Nutritional vitamin D use in chronic kidney disease: a survey of pediatric nephrologists.
Griffin LM; Denburg MR; Shults J; Furth SL; Salusky IB; Hwang W; Leonard MB
Pediatr Nephrol; 2013 Feb; 28(2):265-75. PubMed ID: 23086591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
